[ad_1]
Test of a drug developed by AstraZeneca and UCHL that could guarantee “immediate immunity” up to one year against Coronavirus. The Guardian writes, which claims the therapy could be administered as an emergency treatment to hospitalized patients and nursing home guests to try to break the chain of contagion.
The drug study was renamed “storm chaser.” It is currently in phase three, the most advanced. “If we can demonstrate the effectiveness of this treatment, we could prevent people exposed to the virus from developing the disease – explained Professor Catherine Houlihan, a virologist at UCLH – it would add an additional element to the arsenal of weapons that we are” trying to develop to combat the virus. “. The advantage of this drug could be “immediate immunity.” The drug is currently being tested, with the aim of verifying if the antibody cocktail can protect against the coronavirus for a period of between 6 and 12 months. The subjects involved in the trial receive two doses, one after the other. S.and if approved, treatment will be offered to those who have been exposed to the virus and have not yet developed symptoms. “To date, the drug has been administered to 10 people who have been exposed to the virus at home, in a healthcare setting or in classrooms,” Houlihan explained. The drug could be available on a large scale from March or April 2021 if the green light comes from the national regulator. Dr Richard Jarvis, a committee member for the British Medical Association, explains that it will be important to understand whether trials are effective, but that for new treatments the research process before entering the market is even more important.
[ad_2]
